These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 5381434

  • 21. [Plasma aldosterone and electrolytes in primary and secondard aldosteronism (author's transl)].
    Albert JP, Wronski R, Jentzen F, Hartmann F.
    Med Klin; 1979 Sep 14; 74(37):1315-9. PubMed ID: 492054
    [Abstract] [Full Text] [Related]

  • 22. The syndrome of primary aldosteronism.
    George JM, Wright L, Bell NH, Bartter FC.
    Am J Med; 1970 Mar 14; 48(3):343-56. PubMed ID: 5435648
    [No Abstract] [Full Text] [Related]

  • 23. [Secondary aldosteronism following surgery using the heart-lung machine and its regulation with Aldactone].
    Gleichmann U, Bostroem B, Kreuzer H, Löhr B.
    Anaesthesist; 1965 Dec 14; 14(12):355-9. PubMed ID: 5870012
    [No Abstract] [Full Text] [Related]

  • 24. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure.
    Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Horie H, Sugimoto Y, Kinoshita M.
    J Am Coll Cardiol; 2000 Sep 14; 36(3):838-44. PubMed ID: 10987608
    [Abstract] [Full Text] [Related]

  • 25. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
    Sundsfjord JA, Marton P, Jorgensen H, Aakvaag A.
    J Clin Endocrinol Metab; 1974 Oct 14; 39(4):734-9. PubMed ID: 4370321
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ, Davies DL, Ferriss JB, Fraser R, Haywood E, Lever AF, Robertson JI.
    Br Med J; 1972 Jun 24; 2(5816):729-34. PubMed ID: 4338668
    [Abstract] [Full Text] [Related]

  • 27. [Research on arterial hypertension. Significance of aldosterone, catecholamines, amino acids and some electrolytes in compensated and decompensated cardiac lesions].
    Manta I, Hodîrnău A, Proinov I, Băltescu V, Schneider E.
    Med Interna (Bucur); 1970 Jul 24; 22(7):807-20. PubMed ID: 5506380
    [No Abstract] [Full Text] [Related]

  • 28. Spironolactone in the long-term management of patients with congestive heart failure.
    Smith AG.
    Curr Med Res Opin; 1980 Jul 24; 7(2):131-6. PubMed ID: 7438770
    [Abstract] [Full Text] [Related]

  • 29. [Aldactone in the complex treatment of circulatory insufficiency in elderly patients].
    Morozov KA, Goriainova AN.
    Kardiologiia; 1976 Nov 24; 16(11):150-1. PubMed ID: 1011458
    [No Abstract] [Full Text] [Related]

  • 30. Salivary electrolytes in digitalis-treated patients with and without raised aldosterone excretion.
    von Lilienfeld-Toal H, Buckesfeld RP, Bolte HD, Lankisch PG, Larbig D.
    Klin Wochenschr; 1973 Dec 01; 51(23):1174-6. PubMed ID: 4776565
    [No Abstract] [Full Text] [Related]

  • 31. [Use of aldactone-saltucine in patients with heart failure].
    Bobkova VI, Kartitskií VS, Lapkes TG, Mazurova SV.
    Kardiologiia; 1975 May 01; 15(5):105-8. PubMed ID: 1152318
    [Abstract] [Full Text] [Related]

  • 32. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
    Diercks GF, Overdiek JW, van Veldhuisen DJ.
    Ned Tijdschr Geneeskd; 2001 Feb 03; 145(5):204-8. PubMed ID: 11219145
    [Abstract] [Full Text] [Related]

  • 33. Mineralocorticoid receptor antagonists for heart failure.
    Funder J.
    Expert Opin Pharmacother; 2011 Dec 03; 12(18):2767-9. PubMed ID: 22098225
    [No Abstract] [Full Text] [Related]

  • 34. [Aldosterone, electrolytes and cardiopulmonary insufficiency].
    Shvets LV.
    Vrach Delo; 1969 Jun 03; 6():149-50. PubMed ID: 5821655
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC, Bräuninger HJ.
    MMW Munch Med Wochenschr; 1975 Sep 03; 117(37):1483-6. PubMed ID: 810673
    [Abstract] [Full Text] [Related]

  • 36. Captopril and spironolactone therapy for refractory congestive heart failure.
    Dahlström U, Karlsson E.
    Am J Cardiol; 1993 Jan 21; 71(3):29A-33A. PubMed ID: 8422001
    [Abstract] [Full Text] [Related]

  • 37. [Urinary elimination of water and electrolytes in patients with congestive cardiac insufficiency of different etiologies treated with hygieno-dietetic therapy and cardiotonics. II].
    Tacu V, Arghir A, Scripcaru G, Cosma M, Hodan O, Covic M.
    Rev Med Chir Soc Med Nat Iasi; 1969 Jan 21; 73(2):305-11. PubMed ID: 5801968
    [No Abstract] [Full Text] [Related]

  • 38. [Selective aldosterone blocker for hypertension and heart failure. Better tolerance than previous drugs].
    MMW Fortschr Med; 2002 Sep 26; 144(39):50. PubMed ID: 12422691
    [No Abstract] [Full Text] [Related]

  • 39. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP, Aaronson KD, Koelling TM.
    Am Heart J; 2004 Dec 26; 148(6):971-8. PubMed ID: 15632880
    [Abstract] [Full Text] [Related]

  • 40. [Myocardial hyperexcitability in decompensated cardiopathies. Effect of spironolactone].
    Tourniaire A, Blum J, Guyot R, Madignier M.
    Sem Hop; 1969 Apr 26; 45(20):1388-92. PubMed ID: 4182541
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.